Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy

Keywords

Viral load, Medicine, Antiretroviral therapy, Immunology, Internal medicine

References

• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)Randi Schwartz — 1998
• The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach.Longini Im, Clark Ws, Gardner Li — 1991
• Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G. Deeks, Jason D. Barbour, Robert M. Grant — 2002
• Modeling Markers of Disease Progression by a Hidden Markov Process: Application to Characterizing CD4 Cell DeclineChantal Guihenneuc‐Jouyaux, Sylvia Richardson, Ira M. Longini — 2000
• Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.Brigitte Autran, Guislaine Carcelain, T. S. Li — 1997
• The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapyColette Smith, Caroline Sabin, Fiona Lampe — 2003
• A review and synthesis of the HIV/AIDS epidemic as a multi-stage process.Lynne Billard, Zhen Zhao — 1993
• Use of immunological markers and continuous‐time Markov models to estimate progression of HIV infection in homosexual menJan CM. Hendriks, Glen A. Satten, Ira M. Longini — 1996
• Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapyEvan Wood, Benita Yip, Robert S. Hogg — 2000
• Markov modelling of changes in HIV‐specific cytotoxic T‐lymphocyte responses with time in untreated HIV‐1 infected patientsIsabelle Kousignian, Brigitte Autran, Cécile Chouquet — 2003
• Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.Li Ts, Roland Tubiana, Christine Katlama — 1998
• Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral TherapySophie Grabar, Vincent Le Moing, Cécile Goujard — 2000
• Comparison of the declines in CD4 counts in HIV-1-seropositive female sex workers and women from the general population in Nairobi, Kenya.Job J. Bwayo, Nico Nagelkerke, Stephen Moses — 1995
• Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation.Linda Sharples — 1993
• Resistance profile and cross‐resistance of HIV‐1 among patients failing a non‐nucleoside reverse transcriptase inhibitor‐containing regimen *Constance Delaugerre, Raymond Rohban, Anne Simon — 2001
• Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.Vincent Le Moing, Rodolphe Thiébaut, Geneviève Chêne — 2002
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort studyBruno Ledergerber, Matthias Egger, Milos Opravil — 1999
• Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.Jean-Michel Tassie, Jacques Gasnault, M. Bentata — 1999
• The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.David Katzenstein, Scott M. Hammer, Michael D. Hughes — 1996
• Markov chain Monte Carlo in PracticePeter J Green — 1996

Cited by

• Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinicJ. L. Gregg — 2010
• Avaliação da reconstituição do sistema imune em pacientes infectados pelo HIV-1 em uso de terapia anti-retroviral combinadaRosângela Rodrigues — 2004
• Modèles semi-Markoviens : Application à l'analyse de l'évolution de pathologies chroniquesYohann Foucher — 2007
• Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment ProgrammeVictoria Johnston, Katherine Fielding, Salome Charalambous — 2012
• Markov Modelling of Immunological and Virological States in HIV‐1 Infected PatientsEve Mathieu, P. Loup, P. Dellamonica — 2005
• Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replicationNadia Alatrakchi, Claudine Duvivier, Dominique Costagliola — 2005
• Long‐term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugsVincent Le Moing, Rodolphe Thiébaut, Geneviève Chêne — 2007
• Current practices in laboratory monitoring of HIV infectionMadhu Vajpayee, Teena Mohan — 2011
• Delaying a Treatment Switch in Antiretroviral-Treated HIV Type 1-Infected Patients with Detectable Drug-Resistant Viremia Does Not Have a Profound Effect on Immune Parameters: AIDS Clinical Trials Group Study A5115Allan R. Tenorio, Hongyu Jiang, Yu Zheng — 2009
• CD4+ T-Cell Recovery and Clinical Outcome in HIV-1-Infected Patients Exposed to Multiple Antiretroviral Regimens: Partial Control of Viremia Is Associated with Favorable OutcomeLuís Fernando de Macedo Brígido, Rosângela Rodrigues, Jorge Casseb — 2004
• Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings.Wendy Stevens, Lesley Scott, Suzanne M. Crowe — 2010
• Markov modelling of HIV infection evolution in the HAART eraChristine Binquet, Gwénaël Le Teuff, Michal Abrahamovicz — 2009
• Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDSVincent C. Marconi, Greg Grandits, Jason F. Okulicz — 2011
• Cervical neoplasia and highly active antiretroviral therapy.Xi Liu, Nancy B. Kiviat — 2004
• HIV viral load monitoring in resource-limited regions: optional or necessary?Alexandra Calmy, Nathan Ford, Bernard Hirschel — 2007
• Multi-state models for defining degrees of chronicity related to HIV-infected patient therapy adherence.Raquel de Vasconcellos Carvalhães de Oliveira, Sílvia Emiko Shimakura, Dayse Pereira Campos — 2013
• A Novel, Low-Cost Viral Load Diagnostic for HIV-1 and Assessing Barriers to Adoption of Technology in TanzaniaDamien Salamone — 2011
• A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral TherapyJennifer Gillis, Mona Loutfy, Ahmed M. Bayoumi — 2016
• Optimal Timing to Initiate Medical Treatment for a Disease Evolving as a Semi-Markov ProcessMabel C. Chou, Mahmut Parlar, Yun Zhou — 2017
• Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approachRaquel de Vasconcellos Carvalhães de Oliveira, Sílvia Emiko Shimakura, Dayse Pereira Campos — 2018

Related papers

• The Sexual Behaviours of HIV Positive Patients Receiving Antiretroviral Therapy in HIV Treatment Centre in NigeriaAgu Kenneth Igbe Ighodaro — 2014
• Reverse Transcriptase Viral Load Correlates with RNA in SIV/SHIV-Infected MacaquesGary E. Corrigan, Eva Olausson Hansson, Andreas Mörner — 2006
• HIV RNA level in early infection is predicted by viral load in the transmission sourceFrederick Hecht, Wendy Hartogensis, Larry Bragg — 2010
• Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?Antonia L. Moore, Mike Youle, Marc Lipman — 2002
• Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.Stephen J. Popper, Abdoulaye Dieng Sarr, Karin Travers — 1999
• Estimation of the Predictive role of Plasma Viral load on CD4 decline in HIV-1-subtype C infected subjects in IndiaMing Ding, Patrick M. Tarwater, Milka A. Rodriguez — 2009
• Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populationsAndrea Granados, Kathy Luinstra, Sylvia Chong — 2012
• Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients.Taniya Ahuja, Nimra Niaz, A. Velasco — 1999
• Predictive value of viral load measurements in asymptomatic untreated HIV‐1 infection: a mathematical modelJohn P. A. Ioannidis, Joseph C. Cappelleri, Joseph W.Y. Lau — 1996